The analysis of screening costs for hypercholesterolemia and hyperglycemia as part of obligatory examinations of employees.

cost-effectiveness dyslipidemia economic evaluation hyperglycemia occupational health programs screening

Journal

International journal of occupational medicine and environmental health
ISSN: 1896-494X
Titre abrégé: Int J Occup Med Environ Health
Pays: Poland
ID NLM: 9437093

Informations de publication

Date de publication:
03 Sep 2021
Historique:
pubmed: 23 3 2021
medline: 26 10 2021
entrez: 22 3 2021
Statut: ppublish

Résumé

High prevalence of hyperlipidemia and hyperglycemia requires searching for efficient and cost-effective methods of an early detection of these disorders. In Poland, obligatory employee medical check-ups could be a solution. The study included a group of university employees who underwent obligatory occupational examinations in 2018. Each employee had an additional lipid (unit cost: EUR 2.56) and blood glucose profile (EUR 0.93) done. The number of respondents involved in the study was 850 (340 males and 510 females), and their average age was 47 years (SD = 11 years). The education distribution was as follows: employees with secondary vocational and general education (physical, frontline and administrative workers): 176 (age: M±SD 50.3±10.3); employees with a university degree (academics with an M.Sc. or/and Ph.D. title and administrative staff): 535 (age: M±SD 43.6±9.8); and academics with a university title (Ass. Prof. and/or Prof.): 139 (age: M±SD 56.2±10.2). Dyslipidemia (elevated total cholesterol ≥190 mg/dl and/or low-density lipoprotein cholesterol ≥115 mg/dl) was reported in 560 workers (65.9%). Hyperglycemia (fasting glucose ≥100 mg/dl) was observed in 256 workers (31%). The total cost of detecting a single case of dyslipidemia and hyperglycemia was EUR 3.88 and EUR 3.09, respectively. Divided by age groups, the costs were as follows: EUR 4.34 and EUR 4.53 in the age group <45 years; EUR 3.56 and EUR 2.42 in the age group ≥45 years. The costs of detecting a single case of dyslipidemia and hyperglycemia in employees aged ≥45 with regard to education were as follows: EUR 3.20 and EUR 2.07 in persons with secondary vocational and general education; EUR 3.40 and EUR 2.80 in persons with a university degree; and EUR 4.38 and EUR 2.28 in persons with a university title. Due to the fact that the reporting rate for screening tests in the framework of occupational medicine is high, the cost of occupational screening tests for dyslipidemia and hyperglycemia can be lower than the cost of screening tests in the general population. Int J Occup Med Environ Health. 2021;34(5):581-9.

Identifiants

pubmed: 33749686
pii: 131543
doi: 10.13075/ijomeh.1896.01708
pii:
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

581-589

Informations de copyright

This work is available in Open Access model and licensed under a CC BY-NC 3.0 PL license.

Auteurs

Andrzej Marcinkiewicz (A)

Nofer Institute of Occupational Medicine, Łódź, Poland (Department of Occupational Diseases and Environmental Health).

Dominik Olejniczak (D)

Public Health Committee of the Polish Academy of Sciences, Warsaw, Poland.

Daniel Śliż (D)

Public Health Committee of the Polish Academy of Sciences, Warsaw, Poland.

Anna Staniszewska (A)

Medical University of Warsaw, Warsaw, Poland (Department of Experimental and Clinical Pharmacology).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH